Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Patchett

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|January 1, 1984
The chemistry of enalaprilA A Patchett
Advances in Enzymology and Related Areas of Molecular Biology|January 1, 1985
The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzymeA A Patchett, E H Cordes
Medicinal Research Reviews|October 1, 1985
Recent developments in the design of angiotensin-converting enzyme inhibitorsM J Wyvratt, A A Patchett
Journal of Medicinal Chemistry|February 1, 1975
Substituted pyrazolo corticoids as topical antiinflammatory agentsJ Hannah, K Kelly, A A Patchett
Journal of Medicinal Chemistry|January 1, 1989
Synthesis of an analogue of tabtoxinine as a potential inhibitor of D-alanine:D-alanine ligase (ADP forming)W J Greenlee, J P Springer, A A Patchett
Biochemistry|February 19, 1980
Inactivation of 3-(3,4-dihydroxyphenyl)alanine decarboxylase by 2-(fluoromethyl)-3-(3,4-dihydroxyphenyl)alanineA L Maycock, S D Aster, A A Patchett
Journal of Medicinal Chemistry|January 1, 1977
5,11-dimethyl-2,9-bis(phenylacetyl)-5,11-diazatetracyclo[6.2.2.0(2,7).0(4,9)]dodecane, a potent, novel analgesicM H Fisher, E J Grabowski, A A Patchett, et al.
The Journal of Biological Chemistry|March 10, 1985
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-prolineH G Bull, N A Thornberry, M H Cordes, et al.
Journal of Medicinal Chemistry|February 1, 1980
Synthesis and biological activity of flavipucine analoguesN N Girotra, A A Patchett, S B Zimmerman, et al.
Chemistry & Biology|December 1, 1994
Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptorD J Underwood, C D Strader, R Rivero, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|January 1, 1984
The chemistry of enalaprilA A Patchett
Advances in Enzymology and Related Areas of Molecular Biology|January 1, 1985
The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzymeA A Patchett, E H Cordes
Medicinal Research Reviews|October 1, 1985
Recent developments in the design of angiotensin-converting enzyme inhibitorsM J Wyvratt, A A Patchett
Journal of Medicinal Chemistry|February 1, 1975
Substituted pyrazolo corticoids as topical antiinflammatory agentsJ Hannah, K Kelly, A A Patchett
Journal of Medicinal Chemistry|January 1, 1989
Synthesis of an analogue of tabtoxinine as a potential inhibitor of D-alanine:D-alanine ligase (ADP forming)W J Greenlee, J P Springer, A A Patchett
Biochemistry|February 19, 1980
Inactivation of 3-(3,4-dihydroxyphenyl)alanine decarboxylase by 2-(fluoromethyl)-3-(3,4-dihydroxyphenyl)alanineA L Maycock, S D Aster, A A Patchett
Journal of Medicinal Chemistry|January 1, 1977
5,11-dimethyl-2,9-bis(phenylacetyl)-5,11-diazatetracyclo[6.2.2.0(2,7).0(4,9)]dodecane, a potent, novel analgesicM H Fisher, E J Grabowski, A A Patchett, et al.
The Journal of Biological Chemistry|March 10, 1985
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-prolineH G Bull, N A Thornberry, M H Cordes, et al.
Journal of Medicinal Chemistry|February 1, 1980
Synthesis and biological activity of flavipucine analoguesN N Girotra, A A Patchett, S B Zimmerman, et al.
Chemistry & Biology|December 1, 1994
Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptorD J Underwood, C D Strader, R Rivero, et al.
Pageof 7